Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 Feb 2020
Historique:
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 29 2 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32109238
doi: 10.1038/s41598-020-60492-7
pii: 10.1038/s41598-020-60492-7
pmc: PMC7046641
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

3941

Commentaires et corrections

Type : ErratumFor

Auteurs

Myriam Maoz (M)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Michal Devir (M)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Michal Inbar (M)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Ziva Inbar-Daniel (Z)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Dana Sherill-Rofe (D)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Idit Bloch (I)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Karen Meir (K)

Department of Pathology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

David Edelman (D)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Salah Azzam (S)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Hovav Nechushtan (H)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Ofra Maimon (O)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Beatrice Uziely (B)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Luna Kadouri (L)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Amir Sonnenblick (A)

The Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Amir Eden (A)

Department of Cell & Developmental Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, Jerusalem, Israel.

Tamar Peretz (T)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Aviad Zick (A)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel. aviadz@hadassah.org.il.

Classifications MeSH